Skip to main content
Log in

Efficacy comparison of laparoscopic sleeve gastrectomy in type 2 diabetes patients with a BMI 30–34.9 kg/m2 versus BMI < 30 kg/m2

  • Published:
Surgical Endoscopy Aims and scope Submit manuscript

Abstract

Background

Laparoscopic sleeve gastrectomy (LSG) is safe and effective in type 2 diabetes mellitus (T2DM) with body mass index (BMI) ≥ 35 kg/m2. However, the effect and safety of LSG in the treatment of T2DM patients with BMI less than 35 kg/m2, especially in patients with BMI less than 30 kg/m2, are still debatable.

Methods

A total of 51 T2DM patients with BMI less than 35 kg/m2 treated successfully with LSG were included in our study. All patients were divided into two groups for subgroup analysis, namely group A (BMI 23.23–29.97 kg/m2) and group B (BMI 30.0–34.9 kg/m2). The weight loss and diabetic characteristics of LSG in the two groups at 3 months, 6 months, and 12 months after operation were compared, respectively.

Results

In group A, the complete remission rates of T2DM were 20%, 36%, and 44% at 3, 6, and 12 months after operation, respectively. In group B, the complete remission rates of T2DM were 30.8%, 61.5%, and 88.5% at 3, 6, and 12 months after operation, respectively. Besides, none of the patients with a duration more than 15 years achieved complete remission. For T2DM patients with BMI < 30 kg/m2 at 12 months after LSG, the complete remission rate of T2DM was 15.4% in patients with ABCD scores ≤ 2, and the complete remission rate of T2DM was 100% in patients with ABCD scores ≥ 5.

Conclusion

LSG is safe and effective for T2DM patients with BMI less than 35 kg/m2 in the short-term. However, the complete remission rate of T2DM in patients with BMI less than 30 kg/m2 is far from the diabetes patients with BMI at 30–34.9 kg/m2.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Zheng Y, Ley SH, Hu FB (2018) Global aetiology and epidemiology of type 2 diabetes mellitus and its complications. Nat Rev Endocrinol 14:88–98

    Article  Google Scholar 

  2. Berry MA, Urrutia L, Lamoza P, Molina A, Luna E, Parra F, Dominguez MJ, Alonso R (2018) Sleeve gastrectomy outcomes in patients with BMI between 30 and 35–3 years of follow-up. Obes Surg 28:649–655

    Article  Google Scholar 

  3. DePaula AL, Macedo AL, Rassi N, Machado CA, Schraibman V, Silva LQ, Halpern A (2008) Laparoscopic treatment of type 2 diabetes mellitus for patients with a body mass index less than 35. Surg Endosc 22:706–716

    Article  CAS  Google Scholar 

  4. Pratt JSA, Browne A, Browne NT, Bruzoni M, Cohen M, Desai A, Inge T, Linden BC, Mattar SG, Michalsky M, Podkameni D, Reichard KW, Stanford FC, Zeller MH, Zitsman J (2018) ASMBS pediatric metabolic and bariatric surgery guidelines, 2018. Surg Obes Relat Dis 14:882–901

    Article  Google Scholar 

  5. Rubino F, Nathan DM, Eckel RH, Schauer PR, Alberti KG, Zimmet PZ, Del Prato S, Ji L, Sadikot SM, Herman WH, Amiel SA, Kaplan LM, Taroncher-Oldenburg G, Cummings DE, Delegates of the 2nd Diabetes Surgery S (2017) Metabolic surgery in the treatment algorithm for type 2 diabetes: a Joint Statement by International Diabetes Organizations. Obes Surg 27:2–21

    Article  Google Scholar 

  6. NIH conference (1991) Gastrointestinal surgery for severe obesity. Consensus Development Conference Panel. Ann Intern Med 115:956–961

    Article  Google Scholar 

  7. Cummings DE, Cohen RV (2016) Bariatric/metabolic surgery to treat type 2 diabetes in patients with a BMI <35 kg/m2. Diabetes Care 39:924–933

    Article  Google Scholar 

  8. Li Q, Chen L, Yang Z, Ye Z, Huang Y, He M, Zhang S, Feng X, Gong W, Zhang Z, Zhao W, Liu C, Qu S, Hu R (2012) Metabolic effects of bariatric surgery in type 2 diabetic patients with body mass index < 35 kg/m2. Diabetes Obes Metab 14:262–270

    Article  CAS  Google Scholar 

  9. Selvin E, Steffes MW, Zhu H, Matsushita K, Wagenknecht L, Pankow J, Coresh J, Brancati FL (2010) Glycated hemoglobin, diabetes, and cardiovascular risk in nondiabetic adults. N Engl J Med 362:800–811

    Article  CAS  Google Scholar 

  10. Lee WJ, Hur KY, Lakadawala M, Kasama K, Wong SK, Chen SC, Lee YC, Ser KH (2013) Predicting success of metabolic surgery: age, body mass index, C-peptide, and duration score. Surg Obes Relat Dis 9:379–384

    Article  Google Scholar 

  11. Faul F, Erdfelder E, Buchner A, Lang AG (2009) Statistical power analyses using G*Power 3.1: tests for correlation and regression analyses. Behav Res Methods 41:1149–1160

    Article  Google Scholar 

  12. Lee WJ, Lee YC, Ser KH, Chen JC, Chen SC (2008) Improvement of insulin resistance after obesity surgery: a comparison of gastric banding and bypass procedures. Obes Surg 18:1119–1125

    Article  Google Scholar 

  13. Ugale S, Gupta N, Modi KD, Kota SK, Satwalekar V, Naik V, Swapna M, Kumar KH (2014) Prediction of remission after metabolic surgery using a novel scoring system in type 2 diabetes—a retrospective cohort study. J Diabetes Metab Disord 13:89

    Article  Google Scholar 

  14. Wang GF, Yan YX, Xu N, Yin D, Hui Y, Zhang JP, Han GJ, Ma N, Wu Y, Xu JZ, Yang T (2015) Predictive factors of type 2 diabetes mellitus remission following bariatric surgery: a meta-analysis. Obes Surg 25:199–208

    Article  Google Scholar 

  15. Kim JW, Cheong JH, Hyung WJ, Choi SH, Noh SH (2012) Outcome after gastrectomy in gastric cancer patients with type 2 diabetes. World J Gastroenterol 18:49–54

    Article  Google Scholar 

  16. Scopinaro N, Adami GF, Papadia FS, Camerini G, Carlini F, Briatore L, D'Alessandro G, Parodi C, Weiss A, Andraghetti G, Catalano M, Cordera R (2011) The effects of biliopancreatic diversion on type 2 diabetes mellitus in patients with mild obesity (BMI 30–35 kg/m2) and simple overweight (BMI 25–30 kg/m2): a prospective controlled study. Obes Surg 21:880–888

    Article  Google Scholar 

  17. Scopinaro N, Adami GF, Papadia FS, Camerini G, Carlini F, Fried M, Briatore L, D'Alessandro G, Andraghetti G, Cordera R (2011) Effects of biliopanceratic diversion on type 2 diabetes in patients with BMI 25 to 35. Ann Surg 253:699–703

    Article  Google Scholar 

  18. Torquati A, Lutfi R, Abumrad N, Richards WO (2005) Is Roux-en-Y gastric bypass surgery the most effective treatment for type 2 diabetes mellitus in morbidly obese patients? J Gastrointest Surg 9:1112–1116 discussion 1117–1118

    Article  Google Scholar 

  19. Vetter ML, Cardillo S, Rickels MR, Iqbal N (2009) Narrative review: effect of bariatric surgery on type 2 diabetes mellitus. Ann Intern Med 150:94–103

    Article  Google Scholar 

  20. Kim MK, Lee HC, Lee SH, Kwon HS, Baek KH, Kim EK, Lee KW, Song KH (2012) The difference of glucostatic parameters according to the remission of diabetes after Roux-en-Y gastric bypass. Diabetes/Metabol Res Rev 28:439–446

    Article  CAS  Google Scholar 

  21. Scopinaro N, Adami GF, Papadia FS, Camerini G, Carlini F, Briatore L, Andraghetti G, Catalano M, Cordera R (2014) Effects of gastric bypass on type 2 diabetes in patients with BMI 30 to 35. Obes Surg 24:1036–1043

    Article  Google Scholar 

  22. Lee WJ, Almulaifi A, Chong K, Chen SC, Tsou JJ, Ser KH, Lee YC, Chen JC (2015) The effect and predictive score of gastric bypass and sleeve gastrectomy on type 2 diabetes mellitus patients with BMI < 30 kg/m(2). Obes Surg 25:1772–1778

    Article  Google Scholar 

  23. Lee WJ, Chong K, Ser KH, Chen JC, Lee YC, Chen SC, Su YH, Tsai MH (2012) C-peptide predicts the remission of type 2 diabetes after bariatric surgery. Obes Surg 22:293–298

    Article  Google Scholar 

  24. Buchwald H, Estok R, Fahrbach K, Banel D, Jensen MD, Pories WJ, Bantle JP, Sledge I (2009) Weight and type 2 diabetes after bariatric surgery: systematic review and meta-analysis. Am J Med 122(248–256):e245

    Google Scholar 

  25. Vigneshwaran B, Wahal A, Aggarwal S, Priyadarshini P, Bhattacharjee H, Khadgawat R, Yadav R (2016) Impact of sleeve gastrectomy on type 2 diabetes mellitus, gastric emptying time, glucagon-like peptide 1 (GLP-1), ghrelin and leptin in non-morbidly obese subjects with BMI 30–35.0 kg/m(2): a Prospective Study. Obes Surg 26:2817–2823

    Article  CAS  Google Scholar 

  26. Park JY, Kim YJ (2015) Efficacy of laparoscopic sleeve gastrectomy in mildly obese patients with body mass index of 30–35 kg/m(2). Obes Surg 25:1351–1357

    Article  Google Scholar 

Download references

Funding

The authors received no financial support for the research.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Tao Jiang.

Ethics declarations

Conflict of interest

Diqing Wu, Lun Wang, Tao Jiang have no conflict of interest or financial ties to disclose.

Ethical approval

All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Wu, D., Wang, L. & Jiang, T. Efficacy comparison of laparoscopic sleeve gastrectomy in type 2 diabetes patients with a BMI 30–34.9 kg/m2 versus BMI < 30 kg/m2. Surg Endosc 35, 1544–1550 (2021). https://doi.org/10.1007/s00464-020-07749-4

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00464-020-07749-4

Keywords

Navigation